UNSPSC 41142048: Pyruvate kinase test system

In this classification, Pyruvate kinase test system connotes a device used to measure Pyruvate kinase levels. US FDA regulates Pyruvate kinase test system under 21 CFR 862.1650 and under FDA product code JNJ.

UNSPSC 41142048 Pyruvate kinase test system is a Commodity code that in recent state and local procurement activity encompasses direct-use laboratory testing reagents and certified reference standards for forensic toxicology, drug analysis, and disease surveillance. State and local governments are procuring immunoassay reagent kits for controlled-substance detection (cannabinoids, opiates, PCP, amphetamines, benzodiazepines, cocaine, and related compounds), certified drug reference standards for method validation and evidentiary sample analysis, and diagnostic test kits for vector-borne disease detection such as West Nile Virus and dengue. The issuing bodies include state crime laboratories and forensic divisions (Texas Department of Public Safety, Texas Health and Human Services Commission Department of State Health Services, Pinellas County Forensic Laboratory), state departments of environmental regulation and public health, and county health and forensic agencies. Procurement notices span competitive IFBs, informal ITQs with small-business preference scoring, and sole-source arrangements for proprietary or authorized-distributor test systems.

Activity clusters in Texas and Florida, with Texas Department of Public Safety, Texas HHSC, and Texas Department of Criminal Justice accounting for multiple recent solicitations in 2026 and Pinellas County, Florida, conducting forensic-laboratory procurement under a federal Coverdell grant. Representative recent opportunities include the Texas Department of Public Safety IFB 405-26R0008445A (due July 23, 2026) for direct ELISA testing kits covering 12 controlled-substance line items with estimated quantities of 3 to 30 units per item and delivery to the Crime Lab Division in Austin; Pinellas County Invitation to Quote #26-0305-ITQ (due April 23, 2026) for 131 line items of ISO/IEC 17025 certified drug reference standards with 97% minimum purity, funded through $72,126.85 in federal Coverdell grant awards; and Texas HHSC IFB HHS0016902v2 (due January 29, 2026) for QIAxcel and QIAamp DNA screening kits for the DSHS state laboratory with historical annual spend between $25,050.00 and $30,000.00. The Illinois Department of Financial and Professional Regulation Centralized Maintenance Services conducted a sole-source notice of intent to award for RAMP West Nile Virus and dengue test kits through ADAPCO, LLC in May 2026. Bidders must hold or obtain DEA licensing for Schedule 1 and 2 controlled substances, comply with ISO/IEC 17025 accreditation standards when required, and meet detailed financial documentation and vendor-performance rating requirements.